B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

por Petersen, D L, Krejsgaard, T, Berthelsen, J, Fredholm, S, Willerslev-Olsen, A, Sibbesen, N A, Bonefeld, C M, Andersen, M H, Francavilla, C, Olsen, J V, Hu, T, Zhang, M, Wasik, M A, Geisler, C, Woetmann, A, Odum, N
Publicado 2014